Norway· NO-ID_E9C88D86-CF46-4BE1-8060-24C75192D146
Vigamox
A moxifloxacin product containing moxifloxacin, registered in Norway by Novartis. The same ATC class is registered in 12 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Moxifloxacin is registered in 12 of 19 countries.
Countries holding a registration under ATC S01AE07 (moxifloxacin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Moxifloxacin · ATC S01AE07
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Moxifloxacin
- Manufacturer
- Novartis
- Country
- Norway (NO)
- ATC code
- S01AE07
- ATC class
- Moxifloxacin
- Defined daily dose
- 0.57 mg, AT
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_E9C88D86-CF46-4BE1-8060-24C75192D146
- no_varenummer3463325
- gtin4150043360565
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Moxifloxacin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMoxifloxacinA-S Medication Solutions
- PolandFlomixaFarmak International Sp. z o.o.
- CzechiaMOXIFLOXACIN BROWN & BURKBrown & Burk IR Limited, Dublin
- NetherlandsMoxifloxacine Stulln 5 mg/ml oogdruppels, oplossingPharma Stulln GmbH
- SwedenVigamox 5 mg/ml Ögondroppar, lösningNovartis Sverige AB
- BelgiumKanavig 5 mg/mlNovartis Pharma
- IcelandVigamoxNovartis Healthcare A/S
- FinlandVigamoxNovartis Finland Oy
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Avelox, Moxifloxacin 1a Pharma
- Belgium · Avelox, Kanavig
- Bulgaria · Cimocinox, Moxifloxacin Kabi
- Cyprus · Avelox, Erelan
- Czechia · Avelox, Moxifloxacin Brown & Burk
- Germany · Avalox, Moxifloxacin 1 A Pharma
- Denmark · Moxifloxacin Accord, Moxifloxacin Fresenius Kabi
- Estonia · Avelox, Floxelan
- Spain · Abimox, Actira
- Finland · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- France · Izilox, Moxifloxacine Arrow
- United Kingdom (Northern Ireland) · Avelox, Moxidox
- Greece · Avelox, Mikrobiel
- Croatia · Melvedok, Moksacin 5 Mg/Ml Kapi
- Hungary · Moxibiot, Moxifloxacin Anfarm
- Ireland · Moxifloxacin
- Iceland · Vigamox
- Italy · Avalox, Moxidrop
- Lithuania · Avelox, Ekara
- Luxembourg · Avelox, Kanavig
- Latvia · Avelox, Ekara
- Malta · Erelan, Moxifloxacin Anfarm
- Netherlands · Erelan, Moxifloxacin Hydrochloride Aurobindo
- Poland · Flomixa, Floxamic Neo
- Portugal · Avelox, Bluesar
- Romania · Avelox, Kimoks
- Sweden · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- Slovenia · Kimoks, Moksifloksacin Kabi
- Slovakia · Avelox, Moloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/56a0fbb4-0b57-4831-b662-cae7e011a015 GET /v1/drugs/56a0fbb4-0b57-4831-b662-cae7e011a015?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Øyedråper, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Moksifloksacin",
"merkevare_id": "ID_E9C88D86-CF46-4BE1-8060-24C75192D146",
"name_form_strength": "Vigamox øyedr, oppl 5 mg/ml",
"prescription_group": "C"
}See everything about moxifloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.